Target intelligence / Profile preview

Hemorrhage

01

Overview

Hemorrhage is defined as the escape of blood from the circulatory system due to vascular injury or impaired hemostatic mechanisms (StatPearls, 2023). It is a clinical condition and physiological event rather than a specific molecular target such as a protein, enzyme, or receptor. In a pharmacological context, 'hemorrhage' is an indication for treatment rather than the target itself, with therapeutic interventions aimed at biological components of the coagulation cascade or fibrinolytic system to stop blood loss (NIH, 2022). Drugs such as tranexamic acid target plasminogen to prevent clot breakdown, while others replace specific clotting factors to restore the body's ability to form stable thrombi (PubMed, 2021). Because it lacks a specific molecular structure or binding site, it is classified as an incorrect entry for a drug target database.

Other names
BleedingBlood lossExsanguinationInternal bleedingExternal bleeding
02

Mechanism of action

Pharmacological agents used in the management of hemorrhage typically act as antifibrinolytics (inhibiting plasminogen activation), procoagulants (replacing deficient clotting factors), or vasopressin analogs to promote platelet adhesion and factor release.

03

Biological functions

HemostasisCoagulationVascular integrity
04

Disease associations

TraumaCoagulopathyCardiovascular diseaseGastrointestinal diseasePostpartum hemorrhage
05

Safety considerations

Thromboembolic events (stroke, myocardial infarction, pulmonary embolism)Anaphylaxis (with blood products or factor concentrates)Volume overloadInfection transmission (rare with modern blood products)
06

Interacting drugs

Tranexamic acid

6 more in the full profile.

07

Biomarkers

Hemoglobin levelHematocritProthrombin time (PT)International Normalized Ratio (INR)Activated partial thromboplastin time (aPTT)Fibrinogen levelsThromboelastography (TEG) parameters

Beyond the preview

Go deeper on Hemorrhage.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemorrhage.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call